发明名称 |
Mucin antigen vaccine |
摘要 |
Provided are expression vectors for generating an immune response to a mucin. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal, a mucin antigen and CD40 ligand. Also provided are methods of generating an immune response against cells expressing a mucin by administering an effective amount of the vector. Further provided are methods of generating an immune response against cancer cells expressing a mucin in an individual by administering an effective amount of the vector. Still further provided are methods of overcoming anergy to a mucin self antigen by administering an effective amount of the vector. |
申请公布号 |
US9402920(B2) |
申请公布日期 |
2016.08.02 |
申请号 |
US201414256091 |
申请日期 |
2014.04.18 |
申请人 |
MicroVAX, LLC |
发明人 |
Tang Yucheng;Deisseroth Albert |
分类号 |
A61K48/00;A61K39/00;C07K14/47;C07K14/705;C12N15/85;A61K9/127 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
Frank Jacob;Snyder Glenn |
主权项 |
1. An expression vector for generating in an individual immunity against a mucin antigen, said vector comprising a transcription unit encoding a polypeptide, said encoded polypeptide comprising from the amino terminus, a secretory signal sequence, the mucin antigen, and CD40 ligand, wherein (i) the mucin antigen does not include a transmembrane domain; (ii) the CD40 ligand does not include a transmembrane domain; (iii) the mucin antigen is attached to the amino terminus of the extracellular domain of said CD40 ligand; and (iv) said encoded polypeptide is configured to promote presentation of Class I MHC and activation with expansion of mucin specific Class I MHC restricted cytotoxic lymphocytes. |
地址 |
Warrenton VA US |